Down regulation of vascular endothelial growth factor is associated with decreased inflammation after intravesical onabotulinumtoxina injections combined with hydrodistention for patients with interstitial cystitis - Clinical results and immunohistochemistry analysis

Urology

Volumn 82, Issue 6, 2013, Pages 1452.e1-1452.e6

  Peng, Chung Hsin ^a,b   Jhang, Jia Fong ^a,b   Shie, Jia Heng ^a,b   Kuo, Hann Chorng ^a,b  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b TZU CHI UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; PROTEIN BAX; VASCULOTROPIN;

ADULT; APOPTOSIS; ARTICLE; BLADDER CAPACITY; BLADDER DISTENSION; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTALGIA; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; HYDRODISTENTION; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERSTITIAL CYSTITIS; MALE; MAST CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCORING SYSTEM; STRESS INCONTINENCE; URODYNAMICS; VISUAL ANALOG SCALE; WESTERN BLOTTING;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; BOTULINUM TOXINS, TYPE A; CYSTITIS, INTERSTITIAL; DOWN-REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; NEUROMUSCULAR AGENTS; URINARY BLADDER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84888596235     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2013.09.003     Document Type: Article

References (23)

1. S. Keay Cell signaling in interstitial cystitis/painful bladder syndrome Cell Signal 20 2008 2174 2179
2. Y. Homma, T. Ueda, and H. Tomoe Clinical guidelines for interstitial cystitis and hypersensitive bladder syndrome Int J Urol 16 2009 597 615
3. Y.C. Kuo, and H.C. Kuo The urodynamic characteristics and prognostic factors of patients with interstitial cystitis/bladder pain syndrome IJCP 67 2013 863 869
4. M.R. Saban, J.M. Backer, and M.V. Backer VEGF receptors and neuropillins are expressed in the urothelial and neuronal cells in normal mouse urinary bladder and are upregulated in inflammation Am J Physiol Renal Physiol 295 2008 F60 F72
5. M. Tamaki, R. Saito, and O. Ogawa Possible mechanisms inducing glomerulations in interstitial cystitis: relationship between endoscopic findings and expression of angiogenic growth factors J Urol 172 2004 945 948
6. S.D. Chung, and Y.C. Kuo Kuo HC. Intravesical onabotulinumtoxinA injections for refractory painful bladder syndrome Pain Physician 15 2012 197 202
7. H.C. Kuo Repeated onabotulinumtoxin-A injections provide better results than single injection in treatment of painful bladder syndrome Pain Physician 16 2013 E15 E23
8. J.H. Shie, and H.C. Kuo Higher levels of cell apoptosis and abnormal E-cadherin expression in the urothelium are associated with inflammation in patients with interstitial cystitis/painful bladder syndrome BJU Int 108 2011 E136 E141
9. M.P. O'Leary, G.R. Sant, and F.J. Fowler Jr. The interstitial cystitis symptom index and problem index Urology 49 1997 58 63
10. J.C. Nickel, J. Barkin, and J. Forrest Randomized, double-blind, dose-ranging study of pentosan polysulfate sodium for interstitial cystitis Urology 65 2005 654 658
11. H.C. Kuo, and M.B. Chancellor Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis/painful bladder syndrome BJU Int 104 2009 657 661
12. E. Kaczmarek, A. Gorna, and P. Majewski Techniques of image analysis for quantitative immunohistochemistry Rocz Akad Med Bialymst 49 Suppl 1 2004 155 158
13. M. Shibuya Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis J Biochem Mol Biol 39 2006 469 478
14. M.R. Saban, T.J. Sferra, and C.A. Davis Neuropillin- VEGF signaling pathway acts as a key modulator of vascular, lymphatic, and inflammatory cell responses of the bladder to intravesical BCG treatment Am J Physiol Renal Physiol 299 2010 F1245 F1256
15. H. Kiuchi, A. Tsujimura, and T. Takao Increased vascular endothelial growth factor expression in patients with bladder pain syndrome/interstitial cystitis: its association with pain severity and glomerulations BJU Int 104 2009 826 831
16. M.R. Saban, C.A. Davis, and A. Avelino VEGF signaling mediates bladder neuroplasticity and inflammation in response to BCG BMC Physiol 11 2011 16
17. J.H. Shie, H.T. Liu, and Y.S. Wang Immunohistochemical evidence suggests repeated intravesical application of botulinum toxin A injections may improve treatment efficacy of interstitial cystitis/bladder pain syndrome BJU Int 111 2013 638 646
18. U. Gaur, and B.B. Aggarwal Regulation of proliferation, survival and apoptosis by members of the TNF superfamily Biochem Pharmacol 66 2003 1403 1408
19. J.H. Shie, H.T. Liu, and H.C. Kuo Increased cell apoptosis of urothelium mediated by inflammation in interstitial cystitis/painful bladder syndrome Urology 79 2012 484.e7 484.e13
20. J.H. Shie, H.T. Liu, and H.C. Kuo Protein expression profiling in interstitial cystitis/painful bladder syndrome: a pilot study of proteins associated with inflammation, apoptosis and angiogenesis Urol Sci 23 2012 107 113
21. I. Dolado, A. Swat, and N. Ajenjo p38alpha MAP kinase as a sensor of reactive oxygen species in tumorigenesis Cancer Cell 11 2007 191 205
22. B. Cai, S.H. Chang, and E.B. Becker p38 MAP kinase mediates apoptosis through phosphorylation of BimEL at Ser-65 J Biol Chem 281 2006 25215 25222
23. C. Ambrosino, and A.R. Nebreda Cell cycle regulation by p38 MAP kinases Biol Cell 93 2001 47 51